RNA startup launches with $300M, Merck partnership
ReNAgade Therapeutics is emerging from stealth with a leadership team hailing from Alnylam Pharmaceuticals and Moderna. The company has about 100 employees already. Its headquarters is 640 Memorial Drive in Cambridge, a storied building that's been home to a Ford Motor Co. (NYSE: F) assembly plant, a Polaroid Corp. manufacturing facility and MIT. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2023 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Big pharma ’s patent cliff is fast approaching
A of $10.8bn would look hefty for most acquisitions of smallish and newish companies. But for Merck, a drugs giant known as outside America, the money it is spending to buy Prometheus Biosciences, a biotech firm based in California, is relatively small change. In the world of big pharma such deals…#merck #prometheus #crohn #keytruda #pfizer #pharma #seagen #bellushealth #bottomline (Source: Reuters: Health)
Source: Reuters: Health - May 20, 2023 Category: Consumer Health News Source Type: news

The FTC Wants to Block the $28 Billion Amgen-Horizon Therapeutics Deal
The Federal Trade Commission and its hard-nosed chair Lina Khan have struck again, this time filing a lawsuit in federal court on Tuesday to halt biotech giant Amgen’s $28 billion blockbuster acquisition of Horizon Therapeutics. Consider it a black box warning for the industry’s M&A-dependent…#linakhan #amgen #horizontherapeutics #ftc #phd #horizon #hollyvedova #wellsfargo #pfizer #merck (Source: Reuters: Health)
Source: Reuters: Health - May 16, 2023 Category: Consumer Health News Source Type: news

Moderna's Revolutionary Cancer Vaccine Sets Investors Abuzz
Medical researchers are using what they know about our immune system and computers to make startling advances. There has never been a better time for investors. Shares of Moderna (MRNA) closed Tuesday up 19.6% after company executives announced a jointly developed vaccine showed great efficacy…#moderna #mrna4157v940 #merck #rna #cambridge #pfe #keytrudamercks #keytruda #stephanebancel #bancel (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2023 Category: Consumer Health News Source Type: news

Merck's $1.4B NotPetya insurance payout upheld by court
Merck's insurers can't use an "act of war" clause to deny the pharmaceutical giant an enormous payout to clean up its NotPetya infection, a court has ruled. A New Jersey appellate court this week upheld [PDF] an earlier decision that a group of insurers could not use the war exclusion in their…#merck #notpetya #newjersey #pdf #kremlin #russian #chrisgray #register #peterhedberg #corvusinsurance (Source: Reuters: Health)
Source: Reuters: Health - May 3, 2023 Category: Consumer Health News Source Type: news

5 Ways EdTech is Facilitating Efficient Innovation for Teams
Just over 30 years ago, the development of web-based learning management systems became a new form of textual communication, using education technology as an influential way to approach teaching and... Just over 30 years ago, the development of web-based learning management systems became a new…#edtech #gartner #dotmatics #bristolmyerssquibb #merck #mit #oxford #ryanbrinkman #eveonline #projectdiscovery (Source: Reuters: Health)
Source: Reuters: Health - May 1, 2023 Category: Consumer Health News Source Type: news

Gilead Stock Dives As Light Profit Overshadows Strong Cancer Drug Sales
Biotech giants Gilead Sciences (GILD) and Amgen (AMGN) posted mixed quarters — leading GILD stock and Amgen stock to topple Friday. X For Gilead, total revenue inched down roughly 4% to $6.35 billion, a hair above forecasts for $6.33 billion, according to FactSet. Adjusted earnings came in at…#gileadsciences #gild #amgen #amgn #gilead #covidsalesdive #veklury #merck #roche #rhhby (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news

Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip
topped Wall Street's first-quarter forecasts Thursday while Bristol Myers Squibb (BMY) delivered a mixed performance. Merck stock swung to a gain while and BMY stock toppled. X Cancer treatments Keytruda and Opdivo helped drive growth for Merck and Bristol, respectively. Keytruda sales continued…#bristolmyerssquibb #bmy #xcancer #keytrudaandopdivo #merck #bristol #keytruda #opdivo #gardasil #bristolmyers (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news

Is Moderna Stock A Buy Or A Sell On The Long Road For Its Cancer Vaccine?
stock skidded in April after the company announced the full Phase 2 results of its Merck (MRK)-partnered personalized cancer vaccine. X The companies tested a combination of the vaccine — tailored to patients' individual tumor DNA — added to Merck's cancer drug Keytruda. After a year, more than…#merck #keytruda #moderna #stephanebancel #senatecommittee #pfe #fda #rsv #pfizer #gsk (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news

With negative FDA panel vote, AstraZeneca may look at narrow Lynparza nod in prostate cancer
A panel of external experts for the FDA voted 11 to 1 in support of a narrow approval for AstraZeneca and Merck’s Lynparza, used in tandem with Johnson & Johnson’s Zytiga and a corticosteroid, | A panel of external experts for the FDA voted 11 to 1 in support of a narrow approval for AstraZeneca…#fda #astrazeneca #merck #lynparza #johnsonjohnsons #zytiga #mcrpc #rickpazdur (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news

Gilead Posts Bullish Cancer Drug Sales, But Profit Questions Linger
Biotech giants Gilead Sciences (GILD) and Amgen (AMGN) posted mixed quarters on Thursday — leading GILD stock and Amgen stock to topple. For Gilead, total revenue inched down roughly 4% to $6.35 billion, a hair above forecasts for $6.33 billion, according to FactSet. Adjusted earnings came in at…#gileadsciences #gild #amgen #amgn #gilead #veklury #merck #roche #rhhby #gsk (Source: Reuters: Health)
Source: Reuters: Health - April 28, 2023 Category: Consumer Health News Source Type: news

New Product Launches To Aid Boston Scientific ’s Q1
Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates. A rise in elective surgeries performed and market share gains for some of its products will likely aid the…#bostonscientific #bsx #bostonscientifics #xl #baylis #acotec #q4 #eps #peercomparisons #merck (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2023 Category: Consumer Health News Source Type: news

4 big deal reports: Prometheus stock jumps 70% on Merck buyout
Investing.com -- Here is your Pro Recap of head-turning deal dispatches you may have missed this week. As always, InvestingPro subscribers got this news first. (NASDAQ: ) shares jumped nearly 70% on Monday following the announcement that Merck (NYSE: ) has agreed to acquire the company for $200.00…#investingpro #merck #q323 #bellus #gsk #bellushealth #crc #teckresources #emeritusnormankeevil #tecksboard (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2023 Category: Consumer Health News Source Type: news

Stocks This Week: Buy Merck
There are contrary S&P cycle influences in the coming week. This is post-options expiration week (OPEX) in April which is not as negative an effect as in other months as we can see below. The dynamic weekly S&P cycle has been accurate in the last year. The second graph depicts this cycle. Note…#sp #merck (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2023 Category: Consumer Health News Source Type: news

Earnings Results: Abbott Labs stock soars 8% after earnings beat as people refocus on their health in a post-COVID world
Abbott Laboratories stock rose 8% Wednesday and was the second biggest gainer on the S&P 500 index, after the diagnostics and medical-device company beat earnings estimates for the first quarter. As expected, declining sales of COVID tests were a feature in the release and on the company’s…#abbottlaboratories #abbottabt #eps #johnsonjohnson #robertford #merck #prometheus #abbott #freestylelibre #fda (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2023 Category: Consumer Health News Source Type: news